嚴律南,
Email: yanlunan688@163.com
Citation： 嚴律南, 雷建勇. Current Status and Prospect of Inclusion Criteria of Liver Transplantation for Hepatocellular Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2014, 21(4): 399-405. doi: 10.7507/1007-9424.20140098 Copy
Copyright ? the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. | Yang JD, Roberts LR. Hepatocellular carcinoma:a global view[J]. Nat Rev Gastroenterol Hepatol, 2010, 7(8):448-458. |
| 2. | EI-Serag H, Rudolph KL. Hepatocellular carcinoma:epidemio-logy and molecular carcinogenesis[J]. Gastroenterology, 2007, 132(7):2557-2576. |
| 3. | Belghiti J. Transplantation for liver tumors[J]. Semin Oncol, 2005, 32(6 Suppl 8):29-32. |
| 4. | Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11):693-699. |
| 5. | Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellur carcinoma:expansion of the tumor size limites does not adversely impact survival[J]. Hepatology, 2001, 33(6):1394-1403. |
| 6. | Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma:Hangzhou experiences[J]. Transplantation, 2008, 85(12):1726-1732. |
| 7. | Mazzaferro V, Liovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria:a retrospective, exploatory analysis[J]. Lancet Oncol, 2009, 10(1):35-43. |
| 8. | Ringe B, Pichlmayr R, Wittekind C, et al. Surgical treatment of hepatocellular carcinoma:experience with liver resection and transplantation in 198 patients[J]. World J Surg, 1991, 15(2):270-285. |
| 9. | Iwatsuki S, Starzl TE, Sheahan DG, et al. Hpatic resection versus transplantation for hepatocellular carcinoma[J]. Ann Surg, 1991, 214(3):221-228. |
| 10. | Bismuth H, Chiche L, Adan R, et al. Liver resection versus transplantation in cirrhotic patients with hepatocellular carcinoma in cirrhosis[J]. Ann Surg, 1993, 218(2):145-151. |
| 11. | Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference[J]. J Hepatol, 2001, 35(3):421-430. |
| 12. | Bruix J, Sherman M. Management of hepatocellular carcinoma[J]. Hepatology, 2011, 42(5):1208-1236. |
| 13. | Silva MF, Sherman M. Criteria for liver transplantation for HCC:what should the limits be?[J]. J Hepatol, 2011, 55(5):1137-1147. |
| 14. | Lei JY, Wang WT, Yan LN. "Metroticket" predictor for asses-sing liver transplantation to treat hepatocellular carcinoma:A single-center analysis in mainland China[J]. World J Gastroenterol, 2013, 19(44):8093-8098. |
| 15. | Gruz F, Cleres M, Raffa S, et al. Hepatocellular carcinoma within Milan criteria and beyond:outcomes of liver ttransplantation in a single Argentinia institution[J]. Acta Gastroenterol Latinoam, 2013, 43(2):106-112. |
| 16. | Cillo U, Vitale A, Grigoletto F, et al. Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria[J]. Am J Transplant, 2007, 7(4):972-981. |
| 17. | Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoem-bolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome[J]. Liver Transpl, 2003, 9(6):557-563. |
| 18. | Gordon-Weeks AN, Snaith A, Petrinic T, et al. Systematic review of outcome of downstaging hepatocellular cancer befor liver trans-plantation in patients outside the Milan criteria[J]. Br J Surg, 2011, 98(9):1201-1208. |
| 19. | Lei JY, Wang WT, Yan LN. Down-staging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria[J]. J Gastrointest Surg, 2013, 17(8):1440-1446. |
| 20. | Lei JY, Wang WT, Yan LN. Up-to-seven criteria for hepatocellular carcinoma liver transplantation:a single center analysis[J]. World J Gastroenterol, 2013, 19(36):6077-6083. |
| 21. | de Ataide EC, Garcia M, Mattosinho Tj, et al. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma[J]. Transplant Proc, 2012, 44(8):2438-2440. |
| 22. | Chan SC, Fan ST, Chok KS, et al. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion[J]. Hepatol Int, 2011 Oct 21.[Epub ahead of print]. |
| 23. | D'Amico F, Schwartz M, Vitale A, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria[J]. Liver Transpl, 2009, 15(10):1278-1287. |
| 24. | Raj A, McCall J, Gane E. Validation of the 'Metroticket' predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma[J]. J Hepatol, 2011, 55(5):1063-1068. |
| 25. | Unek T, Karademir S, Arslan NC, et al. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma[J]. World J Gastroenterol, 2011, 17(37):4206-4212. |
| 26. | Sotiropolos GC, Molmenti EP, Omar OS, et al. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the USCF criteria[J]. Eur J Med Res, 2006, 11(11):467-470. |
| 27. | Patel SS, Arrington AK, McKenzie S, et al. Milan criteria and UCSF criteria:A preliminary comparative study of liver transpl-antation outcomes in the United States[J]. Int J Hepatol, 2012, 2012:253517. |
| 28. | Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocelluar carcinoma:comparison of the proposed USCF criteria with the Milan criteria and the Pittsburgh modified TNM criteria[J]. Liver Transpl, 2002, 8(9):765-774. |
| 29. | Leung JY, Zhu AX, Gordon FD, et al. Liver transplantation outcome for early-stage hepatocellular carcinoma:results of a multicenter study[J]. Liver Transpl, 2004, 10(11):1343-1354. |
| 30. | Onaca N, Gary LD, Goldstein RM, et al. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma:a report from the Internation Registry of Hepatic Tumors in Liver Transplantation[J]. Liver Transpl, 2007, 13(3):391-399. |
| 31. | Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded:a 22-year experience with 467 patients at UCLA[J]. Ann Surg, 2007, 246(3):502-509. |
| 32. | Chen JWC, Kow L, Verran DJ, et al. Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) excedes Milan or USCF criteria. An analysis of liver transplantation in HCC in Australia and New Zealand[J]. HBP, 2009, 11(1):81-89. |
| 33. | Ju MK, Choi GH, Huh KH, et al. USCF criteria by pre-transp-lant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria[J]. Hepatogastroenterology, 2010, 57(101):819-825. |
| 34. | Sharma P, Welch K, Hussain H, et al. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era[J]. Dig Dis Sci, 2012, 57(3):806-812. |
| 35. | Nagai S, Abouljoud MS, Kazimi M, et al. Peritransplant Lymp-hopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation[J]. Transplantation, 2013 Nov 8.[Epub ahead of print]. |
| 36. | Schwartz M. Liver transplantation for hepatocellular carcinoma[J]. Gastroenterology, 2004, 127(5):S268-S276. |
| 37. | Toso C, Cader S, Mentha-Dugerdil A, et al. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence[J]. J Hepatobiliary Pancreat Sci, 2013, 20(3):342-347. |
| 38. | Hoffmann K, Hinz U, Hillebrand N, et al. Risk factors of surv-ival after liver transplantation for HCC:a multivariate single-center analysis[J]. Clini Transplant, 2011, 25(5):E541-E551. |
| 39. | Yaprak O, Akyildiz M, Dayangac M, et al. AFP level and histo-logic differentiation predict the survival of patients with liver trans-plantation for hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(3):256-261. |
| 40. | Marelli L, Grasso A, Pleguezuelo M, et al. Tumor size and diff-erenctiation in predicting recurrence of hepatocellular carcinoma after liver transplantation:external validationof a new prognostic score[J]. Ann Surg Oncol, 2008, 15(12):3503-3511. |
| 41. | Kondili LA, Lala A, Gunson B, et al. Primary hepatocellular cancer in the explanted liver:outcome of transplantation and risk factors for HCC recurrence[J]. Eur J Surg Oncol, 2007, 33(7):868-873. |
| 42. | Zou WL, Zang YL, Chen XG, et al. Risk factors for fatal recurr-ence of hepatocellular carcinoma and their role in selecting candi-dates for liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(2):145-151. |
| 43. | Kim BW, Kim YB, Wang HJ, et al. Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma[J]. World J Gastroenterol, 2006, 12(1):99-104. |
| 44. | Han K, Tzimas GN, Barkun JS, et al. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation[J]. Can J Gastroenterol, 2007, 21(1):39-45. |
| 45. | Fan ST. Selection of HCC patients for liver transplantation:the Milan criteira, Hangzhou criteria and beyond[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3):233-234. |
| 46. | Gao T, Xia Q, Qiu de K, et al. Comparison of survival and tumor recurrence rates in patients undergong liver transplantation for hepatitis B-relatied hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria[J]. J Dig Dis, 2013, 14(10):552-558. |
| 47. | Lei JY, Yan LN. Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies[J]. J Gastrointest Surg, 2013, 17(6):1116-1122. |
| 48. | Lei JY, Wang WT, Yan LN. Hangzhou criteria for liver transpl-antation in hepatocellular carcinoma:a single-center experience[J]. Eur J Gastroenterol Hepatol, 2014, 26(2):200-204. |
| 49. | 王鵬, 劉魯明, 孟志強, 等. 2528例原發性肝癌細針穿刺細胞學檢查及其并發癥[J].中華肝臟病雜志, 2007, 15(10):758-762. |
| 50. | 樊嘉, 周儉, 徐泱, 等.肝癌肝移植適應癥的選擇:上海復旦標準[J].中華醫學雜志, 2006, 86(18):1227-1231. |
| 51. | Herrero JI, Sangro B, Quiroga J, et al. Influence of tumor charac-teristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatcellular carcinoma[J]. Liver Transpl, 2001, 7(7):631-636. |
| 52. | Silva M, Moya A, Berenguer M, et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma[J]. Liver Transpl, 2008, 14(10):1449-1460. |
| 53. | Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma:are we sure?[J]. Liver Transpl, 2003, 9(7):693-696. |
| 54. | Kneteman NM, Overholzer J, Sahier MA, et al. Sirolimus-based immunosppression for liver transplantation in the presence of extented criteria for hepatocellular carcinoma[J]. Liver Transpl, 2004, 10(10):1301-1311. |
| 55. | Toso C, Troter J, Wei A, et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma[J]. Liver Transpl, 2008, 14(8):1107-1115. |
| 56. | Toso C, Asthana S, Bigam DL, et al. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplantat recipients database[J]. Hepatology, 2009, 49(3):832-838. |
| 57. | Vitale A, Morales RR, Zanus G, et al. Barcelona clinic liver cancer staging and transplant survival benefit for patients with hepa-tocellular carcinoma:a multicentre, cohort study[J]. Lancet Oncol, 2011, 12(7):654-662. |
| 58. | Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma[J]. Ann Surg, 2013 Oct 3.[Epub ahead of print]. |
| 59. | Zhong JH, Xiang BD, Gong WF, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization[J]. PloS One, 2013, 8(7):e68193. |
| 60. | Otto G, Herber S, Heise M, et al. Response to transarterial chem-oembolization as a biological selection criteria for liver transplantation in hepatocellular carcinoma[J]. Liver Transpl, 2006, 12(8):1260-1267. |
| 61. | Piardi T, Gheza F, Ellero B, et al. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma[J]. Ann Surg Oncol, 2012, 19(6):2020-2026. |
| 62. | Vitale A, D'Amico F, Frigo AC, et al. Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation[J]. Ann Surg Oncol, 2010, 17(9):2290-2302. |
| 63. | Terzi E, Golfieri R, Piscaglia F, et al. Response rate and clinical outcome of HCC after first and repeated cTACE performed 'on demand'[J]. J Hepatol, 2012, 57(6):1258-1267. |
| 64. | Otto G, Schuchmann M, Hoppe-Lotichius M, et al. How to decide about liver transplantation in patients with hepaocellular carcinoma:size and numer of lesions or response to TACE?[J]. J Hepatol, 2013, 59(2):279-284. |
| 65. | Bargellini I, Bozzi E, Campani D, et al. Modified RECIST to assess tumor respones after transarterial chemoembolization of hepatocellular carcinoma:CT-pathologic correlation in 178 liver explants[J]. Eur J Radiol, 2013, 82(5):e212-e218. |
| 66. | Li J, Yan LN, Yang J, et al. Indicatiors of prognosis after liver transplantation in Chinese hepatocellular carcinoma[J]. World J Gastroenterol, 2009, 15(33):4170-4176. |
- 1. Yang JD, Roberts LR. Hepatocellular carcinoma:a global view[J]. Nat Rev Gastroenterol Hepatol, 2010, 7(8):448-458.
- 2. EI-Serag H, Rudolph KL. Hepatocellular carcinoma:epidemio-logy and molecular carcinogenesis[J]. Gastroenterology, 2007, 132(7):2557-2576.
- 3. Belghiti J. Transplantation for liver tumors[J]. Semin Oncol, 2005, 32(6 Suppl 8):29-32.
- 4. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11):693-699.
- 5. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellur carcinoma:expansion of the tumor size limites does not adversely impact survival[J]. Hepatology, 2001, 33(6):1394-1403.
- 6. Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma:Hangzhou experiences[J]. Transplantation, 2008, 85(12):1726-1732.
- 7. Mazzaferro V, Liovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria:a retrospective, exploatory analysis[J]. Lancet Oncol, 2009, 10(1):35-43.
- 8. Ringe B, Pichlmayr R, Wittekind C, et al. Surgical treatment of hepatocellular carcinoma:experience with liver resection and transplantation in 198 patients[J]. World J Surg, 1991, 15(2):270-285.
- 9. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hpatic resection versus transplantation for hepatocellular carcinoma[J]. Ann Surg, 1991, 214(3):221-228.
- 10. Bismuth H, Chiche L, Adan R, et al. Liver resection versus transplantation in cirrhotic patients with hepatocellular carcinoma in cirrhosis[J]. Ann Surg, 1993, 218(2):145-151.
- 11. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference[J]. J Hepatol, 2001, 35(3):421-430.
- 12. Bruix J, Sherman M. Management of hepatocellular carcinoma[J]. Hepatology, 2011, 42(5):1208-1236.
- 13. Silva MF, Sherman M. Criteria for liver transplantation for HCC:what should the limits be?[J]. J Hepatol, 2011, 55(5):1137-1147.
- 14. Lei JY, Wang WT, Yan LN. "Metroticket" predictor for asses-sing liver transplantation to treat hepatocellular carcinoma:A single-center analysis in mainland China[J]. World J Gastroenterol, 2013, 19(44):8093-8098.
- 15. Gruz F, Cleres M, Raffa S, et al. Hepatocellular carcinoma within Milan criteria and beyond:outcomes of liver ttransplantation in a single Argentinia institution[J]. Acta Gastroenterol Latinoam, 2013, 43(2):106-112.
- 16. Cillo U, Vitale A, Grigoletto F, et al. Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria[J]. Am J Transplant, 2007, 7(4):972-981.
- 17. Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoem-bolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome[J]. Liver Transpl, 2003, 9(6):557-563.
- 18. Gordon-Weeks AN, Snaith A, Petrinic T, et al. Systematic review of outcome of downstaging hepatocellular cancer befor liver trans-plantation in patients outside the Milan criteria[J]. Br J Surg, 2011, 98(9):1201-1208.
- 19. Lei JY, Wang WT, Yan LN. Down-staging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria[J]. J Gastrointest Surg, 2013, 17(8):1440-1446.
- 20. Lei JY, Wang WT, Yan LN. Up-to-seven criteria for hepatocellular carcinoma liver transplantation:a single center analysis[J]. World J Gastroenterol, 2013, 19(36):6077-6083.
- 21. de Ataide EC, Garcia M, Mattosinho Tj, et al. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma[J]. Transplant Proc, 2012, 44(8):2438-2440.
- 22. Chan SC, Fan ST, Chok KS, et al. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion[J]. Hepatol Int, 2011 Oct 21.[Epub ahead of print].
- 23. D'Amico F, Schwartz M, Vitale A, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria[J]. Liver Transpl, 2009, 15(10):1278-1287.
- 24. Raj A, McCall J, Gane E. Validation of the 'Metroticket' predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma[J]. J Hepatol, 2011, 55(5):1063-1068.
- 25. Unek T, Karademir S, Arslan NC, et al. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma[J]. World J Gastroenterol, 2011, 17(37):4206-4212.
- 26. Sotiropolos GC, Molmenti EP, Omar OS, et al. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the USCF criteria[J]. Eur J Med Res, 2006, 11(11):467-470.
- 27. Patel SS, Arrington AK, McKenzie S, et al. Milan criteria and UCSF criteria:A preliminary comparative study of liver transpl-antation outcomes in the United States[J]. Int J Hepatol, 2012, 2012:253517.
- 28. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocelluar carcinoma:comparison of the proposed USCF criteria with the Milan criteria and the Pittsburgh modified TNM criteria[J]. Liver Transpl, 2002, 8(9):765-774.
- 29. Leung JY, Zhu AX, Gordon FD, et al. Liver transplantation outcome for early-stage hepatocellular carcinoma:results of a multicenter study[J]. Liver Transpl, 2004, 10(11):1343-1354.
- 30. Onaca N, Gary LD, Goldstein RM, et al. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma:a report from the Internation Registry of Hepatic Tumors in Liver Transplantation[J]. Liver Transpl, 2007, 13(3):391-399.
- 31. Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded:a 22-year experience with 467 patients at UCLA[J]. Ann Surg, 2007, 246(3):502-509.
- 32. Chen JWC, Kow L, Verran DJ, et al. Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) excedes Milan or USCF criteria. An analysis of liver transplantation in HCC in Australia and New Zealand[J]. HBP, 2009, 11(1):81-89.
- 33. Ju MK, Choi GH, Huh KH, et al. USCF criteria by pre-transp-lant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria[J]. Hepatogastroenterology, 2010, 57(101):819-825.
- 34. Sharma P, Welch K, Hussain H, et al. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era[J]. Dig Dis Sci, 2012, 57(3):806-812.
- 35. Nagai S, Abouljoud MS, Kazimi M, et al. Peritransplant Lymp-hopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation[J]. Transplantation, 2013 Nov 8.[Epub ahead of print].
- 36. Schwartz M. Liver transplantation for hepatocellular carcinoma[J]. Gastroenterology, 2004, 127(5):S268-S276.
- 37. Toso C, Cader S, Mentha-Dugerdil A, et al. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence[J]. J Hepatobiliary Pancreat Sci, 2013, 20(3):342-347.
- 38. Hoffmann K, Hinz U, Hillebrand N, et al. Risk factors of surv-ival after liver transplantation for HCC:a multivariate single-center analysis[J]. Clini Transplant, 2011, 25(5):E541-E551.
- 39. Yaprak O, Akyildiz M, Dayangac M, et al. AFP level and histo-logic differentiation predict the survival of patients with liver trans-plantation for hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(3):256-261.
- 40. Marelli L, Grasso A, Pleguezuelo M, et al. Tumor size and diff-erenctiation in predicting recurrence of hepatocellular carcinoma after liver transplantation:external validationof a new prognostic score[J]. Ann Surg Oncol, 2008, 15(12):3503-3511.
- 41. Kondili LA, Lala A, Gunson B, et al. Primary hepatocellular cancer in the explanted liver:outcome of transplantation and risk factors for HCC recurrence[J]. Eur J Surg Oncol, 2007, 33(7):868-873.
- 42. Zou WL, Zang YL, Chen XG, et al. Risk factors for fatal recurr-ence of hepatocellular carcinoma and their role in selecting candi-dates for liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(2):145-151.
- 43. Kim BW, Kim YB, Wang HJ, et al. Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma[J]. World J Gastroenterol, 2006, 12(1):99-104.
- 44. Han K, Tzimas GN, Barkun JS, et al. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation[J]. Can J Gastroenterol, 2007, 21(1):39-45.
- 45. Fan ST. Selection of HCC patients for liver transplantation:the Milan criteira, Hangzhou criteria and beyond[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3):233-234.
- 46. Gao T, Xia Q, Qiu de K, et al. Comparison of survival and tumor recurrence rates in patients undergong liver transplantation for hepatitis B-relatied hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria[J]. J Dig Dis, 2013, 14(10):552-558.
- 47. Lei JY, Yan LN. Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies[J]. J Gastrointest Surg, 2013, 17(6):1116-1122.
- 48. Lei JY, Wang WT, Yan LN. Hangzhou criteria for liver transpl-antation in hepatocellular carcinoma:a single-center experience[J]. Eur J Gastroenterol Hepatol, 2014, 26(2):200-204.
- 49. 王鵬, 劉魯明, 孟志強, 等. 2528例原發性肝癌細針穿刺細胞學檢查及其并發癥[J].中華肝臟病雜志, 2007, 15(10):758-762.
- 50. 樊嘉, 周儉, 徐泱, 等.肝癌肝移植適應癥的選擇:上海復旦標準[J].中華醫學雜志, 2006, 86(18):1227-1231.
- 51. Herrero JI, Sangro B, Quiroga J, et al. Influence of tumor charac-teristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatcellular carcinoma[J]. Liver Transpl, 2001, 7(7):631-636.
- 52. Silva M, Moya A, Berenguer M, et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma[J]. Liver Transpl, 2008, 14(10):1449-1460.
- 53. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma:are we sure?[J]. Liver Transpl, 2003, 9(7):693-696.
- 54. Kneteman NM, Overholzer J, Sahier MA, et al. Sirolimus-based immunosppression for liver transplantation in the presence of extented criteria for hepatocellular carcinoma[J]. Liver Transpl, 2004, 10(10):1301-1311.
- 55. Toso C, Troter J, Wei A, et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma[J]. Liver Transpl, 2008, 14(8):1107-1115.
- 56. Toso C, Asthana S, Bigam DL, et al. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplantat recipients database[J]. Hepatology, 2009, 49(3):832-838.
- 57. Vitale A, Morales RR, Zanus G, et al. Barcelona clinic liver cancer staging and transplant survival benefit for patients with hepa-tocellular carcinoma:a multicentre, cohort study[J]. Lancet Oncol, 2011, 12(7):654-662.
- 58. Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma[J]. Ann Surg, 2013 Oct 3.[Epub ahead of print].
- 59. Zhong JH, Xiang BD, Gong WF, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization[J]. PloS One, 2013, 8(7):e68193.
- 60. Otto G, Herber S, Heise M, et al. Response to transarterial chem-oembolization as a biological selection criteria for liver transplantation in hepatocellular carcinoma[J]. Liver Transpl, 2006, 12(8):1260-1267.
- 61. Piardi T, Gheza F, Ellero B, et al. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma[J]. Ann Surg Oncol, 2012, 19(6):2020-2026.
- 62. Vitale A, D'Amico F, Frigo AC, et al. Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation[J]. Ann Surg Oncol, 2010, 17(9):2290-2302.
- 63. Terzi E, Golfieri R, Piscaglia F, et al. Response rate and clinical outcome of HCC after first and repeated cTACE performed 'on demand'[J]. J Hepatol, 2012, 57(6):1258-1267.
- 64. Otto G, Schuchmann M, Hoppe-Lotichius M, et al. How to decide about liver transplantation in patients with hepaocellular carcinoma:size and numer of lesions or response to TACE?[J]. J Hepatol, 2013, 59(2):279-284.
- 65. Bargellini I, Bozzi E, Campani D, et al. Modified RECIST to assess tumor respones after transarterial chemoembolization of hepatocellular carcinoma:CT-pathologic correlation in 178 liver explants[J]. Eur J Radiol, 2013, 82(5):e212-e218.
- 66. Li J, Yan LN, Yang J, et al. Indicatiors of prognosis after liver transplantation in Chinese hepatocellular carcinoma[J]. World J Gastroenterol, 2009, 15(33):4170-4176.